Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline We've https://financefeeds.com/b2prime-secures-south-africas-fsca-license/